Boris Sepesi

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Figure S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Table S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Table S6 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Figure S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Figure S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Table S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Figure S3 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Table S3 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Table S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Table S4 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Figure S4 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

  2026-06-17

• Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy—IASLC MPR Project

  Journal of Thoracic Oncology · 2026-06-01

• Mucosal Versus Submucosal Lymphovascular Invasion in Early Esophageal Cancer

  Annals of Surgical Oncology · 2026-02-16 · 1 citations

• Imaging predictors of pleural response in stage IV non–small cell lung cancer

  JTCVS Open · 2026-01-31

• OA12.03 Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Resectable Diffuse Pleural Mesothelioma

  Journal of Thoracic Oncology · 2025-10-01

• OA09.01 Machine Learning Assessment of Pathologic Response in Lung Resections After Neoadjuvant Therapy - IASLC MPR Project

  Journal of Thoracic Oncology · 2025-10-01

• Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples

  Nature Communications · 2025-09-26 · 16 citations

• Correction: Inflammation Mediated by Gut Microbiome Promotes Immune Suppression and Lung Adenocarcinoma Progression

  Cancer Immunology Research · 2025-09-08

• Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses

  Nature Medicine · 2025-09-08 · 14 citations

• Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study

  Journal of Thoracic Oncology · 2025-07-25 · 10 citations